Pipeline

Results show a landmark change that could double survival rates in one of the most difficult oncology diagnose…

Survodutide spurred weight loss Wall Street analysts referred to as “Wegovy-like,” and showed sign…

Oruka Therapeutics’ long-acting plaque psoriasis candidate cleared the skin of 63.5% of patients in a phase 2a…

Veradermics has succeeded in its first major test as a newly-minted public company. The biotech's form of oral…

After a series of setbacks for Sanofi’s tolebrutinib, the French company has scored a victory for the multiple…